Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 12, 2020
Catalent announced it has completed its acquisition of MaSTherCell Global.
read more
Wednesday, February 15, 2023
Catalent has completed an expansion project for its clinical supply facility in Singapore at a cost of $2.2 million.
read more
Friday, December 02, 2022
Catalent announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
read more
Catalent announced the successful completion of the tender offer by Catalent Boston, a subsidiary of Catalent Pharma Solutions for all of the outstanding shares of common stock of Juniper.
read more
Wednesday, January 08, 2020
Catalent announced the completion of the purchase of Bristol-Myers Squibb’s biologics, sterile, and oral solid dose product manufacturing and packaging facility in Anagni, Italy.
read more
Catalent has completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
read more
Friday, February 22, 2019
Catalent Pharma Solutions announced the appointment of Kay Schmidt as Senior Vice President, Technical Operations.
read more
Thursday, October 09, 2025
Catalent has signed a global, non-exclusive license agreement with Lisata Therapeutics, securing rights to use Lisata’s proprietary certepetide peptide and its analogs in antibody-drug conjugates (ADCs) developed on Catalent’s SMARTag® technology ...
read more
Thursday, October 20, 2022
Catalent announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri.
read more
Catalent announced the completion of a $3.2 million expansion program at its consumer health manufacturing facilities in Strathroy, Canada and Sorocaba, Brazil.
read more
Tuesday, November 27, 2018
Catalent Pharma Solutions announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage and is scheduled to be completed by the end of 2018.
read more
Friday, February 27, 2015
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today announced several expanded capabilities within its European Clinical ...
read more
Catalent Pharma Solutions has completed an expansion project at its Kansas City, Missouri, facility to significantly increase controlled-temperature storage capabilities for its clinical supply business.
read more
Catalent announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.
read more
Catalent has invested a further $5 million at the company’s Somerset, New Jersey, drug development center of excellence to expand its OptiMelt® hot melt extrusion capabilities.
read more